|
Robin Kral is the Vice President, Business Development of Reata. Mr. Kral joined Reata from the University of Texas Southwestern Medical Center at Dallas (UT Southwestern), where he was Associate Director for Venture Development. At UT Southwestern, he played a leading role in assembling Reata’s project portfolio and developing its business plan. Before joining UT Southwestern, Mr. Kral was in positions of increasing responsibility in research, market and competitive analysis, product development and business development at NPS Pharmaceuticals in Salt Lake City. His last position at NPS was as Director of Business Development. Mr. Kral has B.S. and M.S. degrees in biology from Texas Tech University, and received his M.B.A. from the David Eccles School of Business at the University of Utah | 